Fengyuan Pharmaceutical: Explanation that this transaction complies with the provisions of Article 4 of the “Provisions on Regulating Certain Issues Concerning the Restructuring of Major Assets of Listed Companies”

SZSI · Jan 4, 2023 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

丰原药业：关于本次交易符合《关于规范上市公司重大资产重组若干问题的规定》第四条规定的说明

Fengyuan Pharmaceutical: Explanation that this transaction complies with the provisions of Article 4 of the “Provisions on Regulating Certain Issues Concerning the Restructuring of Major Assets of Listed Companies”

Risk Disclaimer

Statement